in: YY1 IN THE CONTROL OF THE PATHOGENESIS AND DRUG RESISTANCE OF CANCER A Critical Therapeutic Target, BENJAMIN BONAVIDA, Editor, Elsevier Science, Oxford/Amsterdam , London, pp.60-73, 2020
Despite numerous advances in the field of cancer cell biology, the origin of cancer cells and the systemic dis- ruptions in the cancer process of normal cells have not yet been fully identified. However, we certainly know that cancer cells carry genetic and molecular similarities of the early embryonic development indicating an interesting relationship between “birth” and “death.” During the embryonic development process, the soft- ware of system codes to determine cell fate has been designed. Then, cells containing embryonic residues can be directed as a normal cell, cancer cell, or a stem cell. The transcription factor Yin Yang 1 (YY1) has been reported to play critical roles in many biological processes, such as the embryonic development, cell fate spec- ification, regulation of pluripotency, and oncogenesis. In view of these activities, YY1 has been implicated in both the embryonic development and oncogenesis by acting as a bridge linking these two important biological processes. Therefore, in this review, we primarily focus on YY1 investigations linking the embryonic devel- opment, oncogenesis, and stem cell biology.